Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 2.36Cr 2.04Cr 1.91Cr 1.74Cr 3.28Cr 225.88Cr 3.32Cr 22Cr 8.79Cr 113.17Cr 8.87Cr 8.68Cr 376.45Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.64Cr 3.42Cr 3.11Cr 5.85Cr 403.34Cr 5.93Cr 40Cr 16Cr 202.07Cr 16Cr 15Cr 672.19Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+20.00%
Current month+20.00%
1 month+20.00%
3 months-19.23%
6 months-43.24%
Current year+27.27%
1 week 0
Extreme 0.0021
0
1 month 0
Extreme 0.0021
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.69
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+20.00%-36.36%+281.82% 8L
+0.48%-4.52%-26.99%-51.72% 192.03Cr
-0.87%-4.72% - - 177.15Cr
+3.98%-2.13%+0.46%+215.44% 138.56Cr
+1.17%+0.23%-48.01%+60.22% 114.2Cr
+0.05%-0.59%+191.32%+927.78% 111.43Cr
+2.77%-4.53%+49.57%+37.65% 95Cr
-4.07%-6.66%+51.00%+232.41% 95Cr
+2.16%-8.13%+17.93%+77.61% 88Cr
+2.04%+3.99%+89.55%-4.87% 73Cr
Average +0.77%-1.90%+32.05%+197.37% 108.54Cr
Weighted average by Cap. +0.78%-2.62%+31.29%+178.78%

Financials

2015 2016
Net sales 2.55Cr 2.2Cr 2.06Cr 1.88Cr 3.53Cr 243.63Cr 3.58Cr 24Cr 9.48Cr 122.06Cr 9.57Cr 9.36Cr 406.03Cr 3.23Cr 2.79Cr 2.62Cr 2.38Cr 4.48Cr 309.11Cr 4.55Cr 31Cr 12Cr 154.87Cr 12Cr 12Cr 515.15Cr
Net income 54.95L 47.44L 44.5L 40.53L 76.22L 53Cr 77.27L 5.22Cr 2.04Cr 26Cr 2.06Cr 2.02Cr 88Cr 20.61L 17.79L 16.69L 15.21L 28.59L 20Cr 28.99L 1.96Cr 76.69L 9.87Cr 77.39L 75.71L 33Cr
Net Debt 2.48Cr 2.14Cr 2.01Cr 1.83Cr 3.44Cr 237.16Cr 3.49Cr 24Cr 9.23Cr 118.82Cr 9.31Cr 9.11Cr 395.24Cr 1.86Cr 1.6Cr 1.5Cr 1.37Cr 2.57Cr 177.46Cr 2.61Cr 18Cr 6.91Cr 89Cr 6.97Cr 6.82Cr 295.74Cr
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
14/26/14 $0.002100 -40.00% 500
13/26/13 $0.003500 -.--% 52,661
  1. Stock Market
  2. Stocks
  3. AOXG Stock